Correlation Between Structure Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Structure Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Structure Therapeutics and Mineralys Therapeutics,
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Structure and Mineralys is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 1.64 times more return on investment than Mineralys Therapeutics,. However, Structure Therapeutics is 1.64 times more volatile than Mineralys Therapeutics, Common. It trades about 0.06 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 1,500 in Structure Therapeutics American on August 30, 2024 and sell it today you would earn a total of 1,875 from holding Structure Therapeutics American or generate 125.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 98.91% |
| Values | Daily Returns |
Structure Therapeutics America vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Structure Therapeutics |
| Mineralys Therapeutics, |
Structure Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Structure Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |